What does Oxley Bridge Acquisition Limited do?
Oxley Bridge Acquisition Limited is not an operating company in the conventional sense. It is a Cayman Islands exempted company and a special purpose acquisition company, or SPAC, formed to identify and complete a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar transaction with one or more businesses. The company’s Class A ordinary shares trade on Nasdaq under OBA, while its units and warrants trade under OBAWU and OBAWW. The most useful starting point is the company’s official investor-relations overview and its Form 10-Q for the quarter ended March 31, 2026.
Why is OBA different from a normal public company?
A normal public company sells products or services, reports operating revenue, and is valued on recurring earnings and cash flow. OBA has no operating revenue before a transaction. Its economic purpose is to hold IPO proceeds in trust, search for a suitable target, negotiate a transaction, obtain shareholder and regulatory approvals, and then either close the combination or return trust funds to public shareholders. This makes the key analytical questions fundamentally different: target quality, sponsor incentives, redemption behavior, dilution, transaction financing, deadline risk, and the eventual operating company matter more than quarterly “revenue growth.”
How does Oxley Bridge make money before a business combination?
Before completing a transaction, OBA’s only meaningful income source is the return earned on cash and investments in its trust account, plus modest dividend income. The company explicitly states that it will not generate operating revenue until after an initial business combination, at the earliest. Therefore, its pre-deal income statement mainly reflects interest earned on the trust portfolio minus general, administrative, legal, accounting, listing, due-diligence, and sponsor-related costs.
What are the securities and their economics?
The June 2025 IPO sold 25.3 million units at $10.00 each after the underwriters fully exercised the 3.3 million-unit over-allotment option. Each unit consisted of one Class A ordinary share and one-half of one redeemable public warrant. Each whole warrant has an $11.50 exercise price. The company also sold 6.4 million private placement warrants at $1.00 each, including 4.2 million to the sponsor and 2.2 million to Cantor Fitzgerald. These terms are described in the final IPO prospectus and the IPO-closing Form 8-K.
| Security | Amount | Core right | Analytical implication |
|---|---|---|---|
| Class A ordinary shares | 25.3M outstanding, March 31, 2026 | Redemption claim on trust value, subject to transaction process | Public investors can redeem rather than remain invested in the post-deal company. |
| Class B founder shares | 6.325M outstanding, March 31, 2026 | Generally convert one-for-one into Class A shares | Creates sponsor economics and potential dilution. |
| Public warrants | 12.65M implied by half-warrant units | $11.50 exercise price per whole warrant | Potential future dilution if the post-combination share price supports exercise. |
| Private placement warrants | 6.4M issued at IPO | $11.50 exercise price | Aligns sponsor and underwriter with deal completion, but adds dilution complexity. |
What does OBA’s latest quarter show?
For the quarter ended March 31, 2026, OBA reported no operating revenue, a $162,277 loss from operations, $2.2706 million of income on trust investments, $7,813 of dividend income, and net income of $2.1161 million. Basic and diluted earnings were $0.07 per share for the redeemable Class A shares. These results are mechanically positive because trust income exceeded administrative costs; they do not yet reveal whether OBA will create value through a transaction.
How did the balance sheet change?
| Metric | March 31, 2026 | December 31, 2025 | Interpretation |
|---|---|---|---|
| Cash and cash equivalents | $816,134 | $978,307 | Outside-trust liquidity declined as search and public-company costs consumed cash. |
| Investments in Trust Account | $260.498M | $258.227M | The trust grew by investment income. |
| Total assets | $261.479M | $259.327M | Nearly all assets remain tied to the redemption-protected trust. |
| Current liabilities | $146,923 | $111,507 | Accrued expenses and payables rose modestly. |
| Deferred underwriting fee | $12.045M | $12.045M | Payable upon completion of a business combination. |
| Redemption value per public share | About $10.30 | About $10.21 | Trust accretion increased the approximate redemption value. |
What does the 2025 annual report add?
The 2025 Form 10-K provides the first full-year baseline after the IPO. At December 31, 2025, trust investments were $258.227 million, cash outside the trust was $978,307, total assets were $259.327 million, and public shares subject to redemption were carried at approximately $10.21 per share. The company reported $5.227 million of trust investment income, $18,665 of dividend income, $463,503 of operating loss, and $4.782 million of net income for 2025.
Why is reported profitability easy to misread?
The 2025 net margin concept is not meaningful because OBA had no operating revenue. Instead, a better pre-deal measure is cost coverage: trust and dividend income of $5.246 million exceeded the $463,503 operating loss by roughly 11.3 times. That coverage supports accounting profitability while interest rates remain favorable and trust capital remains intact. Yet the economics belong largely to redeeming public shareholders unless a transaction closes, and the trust cannot be treated as ordinary unrestricted corporate cash.
What does cash flow reveal?
OBA ended 2025 with $978,307 of cash outside the trust after receiving $253.0 million from unit sales and $6.4 million from private placement warrants, paying $4.4 million of underwriting fees, repaying $242,318 of sponsor financing, and paying $331,251 of offering costs. The company also recorded a $12.045 million deferred underwriting fee. This separation between trust assets and working capital is crucial: the trust is large, but the amount available for day-to-day deal search and public-company costs is comparatively small.
Which strategic milestones shaped OBA’s current position?
OBA’s history is short, but each milestone directly affects its capital structure and remaining time to execute.
-
August 6, 2024OBA was incorporated in the Cayman Islands as a blank-check company, establishing the legal shell that would later raise public capital.
-
May 2025A share capitalization increased founder shares to 6.325 million, setting the sponsor’s 20% founder-share position after the IPO.
-
June 24, 2025The IPO registration statement became effective and the offering was priced at $10.00 per unit.
-
June 26, 2025The IPO closed with 25.3 million units after full exercise of the over-allotment option, raising $253.0 million gross.
-
August 15, 2025Class A shares and warrants became eligible for separate trading, allowing investors to choose redemption exposure, warrant optionality, or both.
-
December 31, 2025Trust investments reached $258.227 million and the approximate redemption value rose to $10.21 per share.
-
March 31, 2026Trust investments rose to $260.498 million, or about $10.30 per public share, while no operating business had yet been acquired.
-
June 26, 2027Current deadline to complete a business combination unless validly amended; failure would generally require redemption and liquidation.
What has not happened yet?
As of the March 2026 filing, OBA had not completed a business combination. That absence is the central fact. No target means there is no operating revenue base, no product portfolio, no customer concentration, no industry margin profile, and no post-merger capital structure to model. Any valuation beyond trust value and warrant optionality would therefore be speculative. The next decisive milestone is not another quarter of interest income; it is a signed transaction with enough disclosure to evaluate target quality, valuation, financing, governance, and redemption sensitivity.
What gives OBA a competitive advantage in the SPAC market?
A SPAC’s potential advantage comes from sponsor sourcing ability, transaction judgment, access to financing, credibility with sellers, and execution discipline. OBA’s official leadership page identifies Jonathan Lin as chairman and chief executive officer, Gary Chan as chief financial officer, and Jessie Yan as president. Their backgrounds are relevant because a SPAC has no operating moat before a deal; the sponsor team itself is the primary intangible resource.
Who are OBA’s real competitors?
OBA competes with other SPAC sponsors, private-equity funds, strategic acquirers, family offices, venture investors, and traditional IPO routes for attractive private-company targets. Rivalry rises when capital is abundant and many buyers pursue a limited pool of high-quality assets. Sellers can compare valuation, speed, certainty, sponsor reputation, financing commitments, board composition, and post-close support. Because OBA may pursue any industry, its competitive set is broad rather than sector-specific.
| Competitive factor | Why sellers care | OBA implication |
|---|---|---|
| Transaction certainty | Redemptions and financing gaps can derail closing. | OBA must structure credible financing and manage redemption risk. |
| Sponsor reputation | Private companies want partners who can support public-market transition. | Management credentials are a core differentiator. |
| Valuation discipline | Sellers seek attractive terms, while public investors demand a defensible price. | Overpaying can destroy post-close performance even if the deal completes. |
| Speed and flexibility | A SPAC can sometimes offer a negotiated alternative to an IPO. | OBA’s structure may appeal where execution speed matters. |
Who owns OBA, and why does sponsor control matter?
As of March 30, 2026, OBA had 31.625 million ordinary shares outstanding: 25.3 million Class A public shares and 6.325 million Class B founder shares. Oxley Bridge Holdings LLC held all founder shares, representing 20.23% of total outstanding ordinary shares. Jonathan Lin, through his control of the sponsor’s managing entities, had voting and investment discretion over those shares. Officers and directors as a group were reported with the same 6.325 million-share beneficial position.
How do incentives align and diverge?
The sponsor’s founder shares and private placement warrants can become valuable if a transaction closes and the post-deal securities perform. They can become largely worthless if no business combination occurs. That structure creates a strong incentive to complete a deal, which aligns with public holders who want a compelling transaction but can diverge if the sponsor prefers a mediocre deal to liquidation. Public shareholders retain redemption rights, while founder shares generally waive redemption and liquidation rights with respect to the trust.
| Holder or group | Economic position | Voting influence | Why it matters |
|---|---|---|---|
| Public Class A holders | 25.3M redeemable shares | 79.77% of ordinary shares collectively | Can approve or redeem around a proposed transaction. |
| Oxley Bridge Holdings LLC | 6.325M founder shares plus 4.2M private warrants | 20.23% of ordinary shares | Sponsor economics strongly favor successful deal completion. |
| Jonathan Lin | Beneficial control through sponsor structure | Voting and investment discretion over founder shares | Concentrates sponsor decision influence. |
| Cantor Fitzgerald | 2.2M private placement warrants and deferred fee role | No founder-share control disclosed | Economically exposed to completion through warrants and fees. |
Which KPIs matter most for OBA?
The correct KPI set for a pre-combination SPAC is narrow but highly decision-useful. Researchers should focus on trust value per share, cash outside the trust, monthly expense burn, time to deadline, redemption levels after a deal is announced, financing commitments, dilution from founder shares and warrants, and the valuation paid for the target.
How should liquidity be interpreted?
At March 31, 2026, current assets were $962,384 and current liabilities were $146,923, producing working capital of roughly $815,461. That is adequate for near-term public-company costs on the reported balance sheet, but it is small relative to the potential expense of negotiating and closing a complex transaction. Sponsor or affiliate working-capital loans may therefore become relevant. Up to $1.5 million of such loans may be convertible into post-combination warrants at $1.00 per warrant, adding another potential dilution channel.
What risks could change OBA’s outlook?
The principal risk is binary execution: OBA must identify, negotiate, finance, approve, and close a suitable transaction before its deadline. The 2025 annual report’s risk discussion emphasizes that there is no assurance a business combination will be completed. Even if a deal is announced, public shareholders may redeem heavily, financing markets may weaken, regulators may delay approval, or the target’s forecasts and controls may prove unreliable.
What financial lines are most exposed?
Outside-trust cash is exposed to ongoing legal, accounting, due-diligence, insurance, and administrative spending. The deferred underwriting fee reduces cash available at closing. Trust value is comparatively protected but can be affected by permitted tax payments and redemption mechanics. After a target is announced, the most important numbers will shift to pro forma cash, debt, transaction fees, sponsor dilution, warrant liabilities, redemption levels, PIPE proceeds, and the target’s historical revenue and free cash flow.
Why does the broad target mandate matter?
OBA may pursue a business in any industry. Flexibility widens the sourcing universe, but it also means investors cannot currently underwrite sector economics. A technology target could bring recurring revenue and high valuation sensitivity; an industrial target could bring working-capital and capex demands; a financial target could add regulatory capital constraints. Until a definitive agreement is filed, the risk profile remains intentionally undefined.
Why does OBA matter for valuation?
A conventional discounted cash flow model is not yet appropriate for OBA because there is no operating forecast to discount. The most relevant pre-deal framework separates three components: trust value attributable to public shares, the probability and quality of a future transaction, and warrant optionality. Trust value provides a measurable anchor; the deal component remains uncertain; warrants offer upside only if a post-combination share price exceeds the exercise economics and dilution, redemption, and transaction risks are manageable.
What changes after a deal announcement?
Once OBA signs a definitive agreement, valuation work should pivot to the target’s revenue durability, margins, customer concentration, capital intensity, debt, free cash flow, management quality, and valuation paid. Analysts should reconcile enterprise value to equity value, subtract transaction fees and debt, add cash actually delivered after redemptions, and model dilution from founder shares, warrants, PIPE securities, earnouts, and equity incentives. The announced headline valuation is rarely the same as the fully diluted economic valuation.
What should students and investors monitor next?
The company’s next meaningful disclosures will determine whether the story remains a trust-value vehicle or becomes an operating-company investment. Monitoring should be disciplined and transaction-specific rather than driven by small quarterly changes in interest income.
- A definitive business-combination agreement, including target identity, industry, valuation, and transaction structure.
- The amount of cash expected to reach the target after redemptions, fees, and financing.
- Any PIPE, debt, forward-purchase, backstop, or non-redemption commitments.
- The target’s audited historical financial statements and quality of earnings.
- Sponsor promote modifications, warrant exchanges, earnouts, or other dilution changes.
- Outside-trust cash burn and any working-capital loans from the sponsor.
- Nasdaq listing compliance and any amendment to the June 26, 2027 deadline.
- Shareholder redemption levels and the resulting pro forma capital structure.
What is the central analytical tension?
OBA has a substantial, interest-earning trust and a sponsor position designed to motivate deal completion. Those are strengths for executing a transaction, but they also create the central tension: public shareholders need a deal that is better than redemption value, while the sponsor may have strong incentives to close any acceptable deal before the deadline. The quality of governance, valuation discipline, financing certainty, and target fundamentals will decide whether that tension is resolved constructively.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
